Lonza Posts Lower Sales, Earnings But Expects Capsules Business Rebound This Year
The life-sciences company expects its capsules and health business to return to growth in 2025, after sales and earnings fell ...
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
To access the live webcast and archived recording of the event, visit the Events & Presentations section of the Phathom website at ...
Pharm Exec5d
FDA Approves Two Generics from Amneal Pharmaceuticals for Alzheimer and Oncology, with Tentative Approval for Gastrointestinal Disease
As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...
The Financial11d
The pharmaceutical industry, grappling with new government limits on drug prices
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
GlobalData on MSN8d
Health Canada gives Takeda’s mCRC capsules market authorisation
Health Canada has granted market authorisation to Takeda Canada for FRUZAQLA capsules to treat adults with mCRC.
Hosted on MSN11d
IMPACT ovarian cancer capsules authorised in China
"IMPACT ovarian cancer capsules authorised in China" was originally created and published by Pharmaceutical Technology, a ...
Amneal Pharmaceuticals Gets FDA Approval for Alzheimer's Treatment and Brain Tumor Drug
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...